Future Drug Treatments for Type 1 Diabetes
A multitude of new treatment options for individuals living with type 1 diabetes mellitus
(T1DM) are currently in development or have recently been approved. Recognizing the …
(T1DM) are currently in development or have recently been approved. Recognizing the …
New advances in the treatment of type 2 diabetes
AOM Alshehri - dea.lib.unideb.hu
Diabetes mellitus is characterized by chronic hyperglycemia with disturbances of
carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin …
carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin …
How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?
KM Munir, SN Davis - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
The discovery of insulin over 100 years ago provided a muchneeded lifeline for patients with
diabetes. Since that time patients with type 1 diabetes (T1DM) have seen progress in the …
diabetes. Since that time patients with type 1 diabetes (T1DM) have seen progress in the …
Recent advances in insulin therapy
LM Wilson, JR Castle - Diabetes Technology & Therapeutics, 2020 - liebertpub.com
Insulin therapy has advanced remarkably over the past few decades. Ultra-rapid-acting and
ultra-long-acting insulin analogs are now commercially available. Many additional insulin …
ultra-long-acting insulin analogs are now commercially available. Many additional insulin …
Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus
P Modi - Current drug discovery technologies, 2007 - ingentaconnect.com
Diabetes mellitus (DM) is a progressive disease characterized by insulin deficiency and
insulin resistance or both. The fasting and post-prandial blood glucose is elevated, exposing …
insulin resistance or both. The fasting and post-prandial blood glucose is elevated, exposing …
Recent advances in therapeutic approaches to type 2 diabetes
JM Nuss, AS Wagman - 2000 - Elsevier
Publisher Summary This chapter focuses on advances in therapeutic approaches to type 2
diabetes. In the US, about 10% of the diabetic population suffers from Type 1 diabetes, an …
diabetes. In the US, about 10% of the diabetic population suffers from Type 1 diabetes, an …
Current and new long-acting insulin analogs in development: the quest for a better basal insulin
DR Owens, J Rosenstock - Therapy for Diabetes Mellitus and …, 2014 - books.google.com
David R. Owens, CBE, MD, FRCP Julio Rosenstock, MD glucose levels in diabetes, limited
only by hypoglycemia. Following the epochmaking discovery by Banting and Best in 1922, 1 …
only by hypoglycemia. Following the epochmaking discovery by Banting and Best in 1922, 1 …
New approaches to diabetes
ER Larson, DA Clark, RW Stevenson - Annual Reports in Medicinal …, 1990 - Elsevier
Publisher Summary Several new mechanisms for the therapy of diabetes show considerable
promise for the expansion of the clinical options for the treatment of hyperglycemia. As new …
promise for the expansion of the clinical options for the treatment of hyperglycemia. As new …
Insulin therapies–past, present and future
O Pillai, R Panchagnula - Drug discovery today, 2001 - Elsevier
The discovery of insulin is one of the greatest milestones in medical history. This discovery
revolutionized the use of peptides and proteins as therapeutic agents. For more than six …
revolutionized the use of peptides and proteins as therapeutic agents. For more than six …
The promising future of insulin therapy in diabetes mellitus
R Cheng, N Taleb… - American Journal …, 2021 - journals.physiology.org
The first therapeutic use of insulin by Frederick Banting and Charles Best in 1921
revolutionized the management of type 1 diabetes and considerably changed the lives of …
revolutionized the management of type 1 diabetes and considerably changed the lives of …